Public list Pharma Startups (6570):
Inflazome develops orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome, which drives many chronic inflammatory conditions.
Company (Alive / Active)
Phone: +353 1 687 5002
32 Kildare St
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)